Replies to post #111120 on Biotech Values

[genisi]

Good call on Letairis in IPH:

Gilead Terminates Phase III Clinical Trial of Ambrisentan in Patients with Idiopathic Pulmonary Fibrosis

http://finance.yahoo.com/news/Gilead-Terminates-Phase-III-bw-3130798699.html?x=0

[DewDiligence]

Another IPF candidate:

http://finance.yahoo.com/news/Amira-Pharmaceuticals-prnews-534661588.html?x=0&.v=1

Did you know about this one?